Comments on Strang et al. (2016): 'Clinical provision of improvised nasal naloxone without experimental testing and without regulatory approval: imaginative shortcut or dangerous bypass of essential safety procedures?'
- PMID: 27412451
- DOI: 10.1111/add.13399
Comments on Strang et al. (2016): 'Clinical provision of improvised nasal naloxone without experimental testing and without regulatory approval: imaginative shortcut or dangerous bypass of essential safety procedures?'
Keywords: Ethics and research; heroin overdose; layperson naloxone; nasal naloxone; off-label use of medicine; opioid overdose; overdose prevention; people who use drugs.
Comment in
-
Letters to Addiction from Coffin et al. and Doe-Simpkins et al. re: 'For Debate' on clinical use of improvised nasal naloxone sprays: authors' response.Addiction. 2016 Oct;111(10):1881-3. doi: 10.1111/add.13468. Epub 2016 Jul 13. Addiction. 2016. PMID: 27412695 No abstract available.
Comment on
-
Clinical provision of improvised nasal naloxone without experimental testing and without regulatory approval: imaginative shortcut or dangerous bypass of essential safety procedures?Addiction. 2016 Apr;111(4):574-82. doi: 10.1111/add.13209. Epub 2016 Feb 3. Addiction. 2016. PMID: 26840916
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
